CD14 and systemic sclerosis: Andrews and colleagues [21] did not find a significant difference in the percentage of CD14+ PBMCs between SSc and healthy controls using a fluorescence microscopy method, whereas an increased population of CD14+ PBMCs in SSc patients were found by flow cytometry in our study.